These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
505 related articles for article (PubMed ID: 26276665)
1. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia. Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665 [TBL] [Abstract][Full Text] [Related]
2. Erythroferrone: the missing link in β-thalassemia? Moura IC; Hermine O Blood; 2015 Oct; 126(17):1974-5. PubMed ID: 26494918 [TBL] [Abstract][Full Text] [Related]
3. Identification of erythroferrone as an erythroid regulator of iron metabolism. Kautz L; Jung G; Valore EV; Rivella S; Nemeth E; Ganz T Nat Genet; 2014 Jul; 46(7):678-84. PubMed ID: 24880340 [TBL] [Abstract][Full Text] [Related]
4. Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia. Olivera J; Zhang V; Nemeth E; Ganz T Blood Adv; 2023 Jul; 7(14):3339-3349. PubMed ID: 36995275 [TBL] [Abstract][Full Text] [Related]
6. The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry. Castro-Mollo M; Gera S; Ruiz-Martinez M; Feola M; Gumerova A; Planoutene M; Clementelli C; Sangkhae V; Casu C; Kim SM; Ostland V; Han H; Nemeth E; Fleming R; Rivella S; Lizneva D; Yuen T; Zaidi M; Ginzburg Y Elife; 2021 May; 10():. PubMed ID: 34002695 [TBL] [Abstract][Full Text] [Related]
7. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia. Nai A; Pagani A; Mandelli G; Lidonnici MR; Silvestri L; Ferrari G; Camaschella C Blood; 2012 May; 119(21):5021-9. PubMed ID: 22490684 [TBL] [Abstract][Full Text] [Related]
8. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis. Gutschow P; Schmidt PJ; Han H; Ostland V; Bartnikas TB; Pettiglio MA; Herrera C; Butler JS; Nemeth E; Ganz T; Fleming MD; Westerman M Haematologica; 2015 Feb; 100(2):167-77. PubMed ID: 25425686 [TBL] [Abstract][Full Text] [Related]
9. Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice. Li H; Choesang T; Bao W; Chen H; Feola M; Garcia-Santos D; Li J; Sun S; Follenzi A; Pham P; Liu J; Zhang J; Ponka P; An X; Mohandas N; Fleming RE; Rivella S; Li G; Ginzburg YZ Blood; 2017 Mar; 129(11):1514-1526. PubMed ID: 28151426 [TBL] [Abstract][Full Text] [Related]
10. Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia. De Franceschi L; Daraio F; Filippini A; Carturan S; Muchitsch EM; Roetto A; Camaschella C Haematologica; 2006 Oct; 91(10):1336-42. PubMed ID: 17018382 [TBL] [Abstract][Full Text] [Related]
11. Erythroid overproduction of erythroferrone causes iron overload and developmental abnormalities in mice. Coffey R; Jung G; Olivera JD; Karin G; Pereira RC; Nemeth E; Ganz T Blood; 2022 Jan; 139(3):439-451. PubMed ID: 34614145 [TBL] [Abstract][Full Text] [Related]
12. Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia. El-Gamal RAE; Abdel-Messih IY; Habashy DM; Zaiema SEG; Pessar SA Ann Hematol; 2020 Jan; 99(1):31-39. PubMed ID: 31834456 [TBL] [Abstract][Full Text] [Related]
13. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia. Schmidt PJ; Toudjarska I; Sendamarai AK; Racie T; Milstein S; Bettencourt BR; Hettinger J; Bumcrot D; Fleming MD Blood; 2013 Feb; 121(7):1200-8. PubMed ID: 23223430 [TBL] [Abstract][Full Text] [Related]
14. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models. Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567 [TBL] [Abstract][Full Text] [Related]
15. Erythroferrone structure, function, and physiology: Iron homeostasis and beyond. Srole DN; Ganz T J Cell Physiol; 2021 Jul; 236(7):4888-4901. PubMed ID: 33372284 [TBL] [Abstract][Full Text] [Related]
16. RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermedia. Schmidt PJ; Liu K; Visner G; Fitzgerald K; Fishman S; Racie T; Hettinger JL; Butler JS; Fleming MD Am J Hematol; 2018 Jun; 93(6):745-750. PubMed ID: 29498084 [TBL] [Abstract][Full Text] [Related]
17. Erythroferrone contributes to recovery from anemia of inflammation. Kautz L; Jung G; Nemeth E; Ganz T Blood; 2014 Oct; 124(16):2569-74. PubMed ID: 25193872 [TBL] [Abstract][Full Text] [Related]
18. Erythropoietic regulators of iron metabolism. Ganz T Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834 [TBL] [Abstract][Full Text] [Related]
19. Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia. Mirciov CS; Wilkins SJ; Dunn LA; Anderson GJ; Frazer DM PLoS One; 2017; 12(1):e0171054. PubMed ID: 28135344 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of Erythroferrone, Hepcidin, and Iron Overload Status in Iraqi Transfusion-Dependent β-Thalassemia Major Patients. Smesam HNK; Albuthabhak HAQ; Arjmand S; Al-Hakeim HK; R Siadat SO Hemoglobin; 2020 Jul; 44(4):272-277. PubMed ID: 32718192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]